Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells

Jihye Yun, Carlo Rago, Ian Cheong, Ray Pagliarini, Philipp Angenendt, Harith Rajagopalan, Kerstin Schmidt, James K V Willson, Sandy Markowitz, Shibin Zhou, Luis A. Diaz, Victor E. Velculescu, Christoph Lengauer, Kenneth W. Kinzler, Bert Vogelstein, Nickolas Papadopoulos

Research output: Contribution to journalArticle

507 Citations (Scopus)

Abstract

Tumor progression is driven by genetic mutations, but little is known about the environmental conditions that select for these mutations. Studying the transcriptomes of paired colorectal cancer cell lines that differed only in the mutational status of their KRAS or BRAF genes, we found that GLUT1, encoding glucose transporter-1, was one of three genes consistently up-regulated in cells with KRAS or BRAF mutations. The mutant cells exhibited enhanced glucose uptake and glycolysis and survived in low-glucose conditions, phenotypes that all required GLUT1 expression. In contrast, when cells with wild-type KRAS alleles were subjected to a low-glucose environment, very few cells survived. Most surviving cells expressed high levels of GLUT1, and 4% of these survivors had acquired KRAS mutations not present in their parents. The glycolysis inhibitor 3-bromopyruvate preferentially suppressed the growth of cells with KRAS or BRAF mutations. Together, these data suggest that glucose deprivation can drive the acquisition of KRAS pathway mutations in human tumors.

Original languageEnglish (US)
Pages (from-to)1555-1559
Number of pages5
JournalScience
Volume325
Issue number5947
DOIs
StatePublished - 2009

Fingerprint

Glucose
Mutation
Neoplasms
Glycolysis
Facilitative Glucose Transport Proteins
Transcriptome
Genes
Colorectal Neoplasms
Alleles
Phenotype
Cell Line
Growth

ASJC Scopus subject areas

  • General

Cite this

Yun, J., Rago, C., Cheong, I., Pagliarini, R., Angenendt, P., Rajagopalan, H., ... Papadopoulos, N. (2009). Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells. Science, 325(5947), 1555-1559. https://doi.org/10.1126/science.1174229

Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells. / Yun, Jihye; Rago, Carlo; Cheong, Ian; Pagliarini, Ray; Angenendt, Philipp; Rajagopalan, Harith; Schmidt, Kerstin; Willson, James K V; Markowitz, Sandy; Zhou, Shibin; Diaz, Luis A.; Velculescu, Victor E.; Lengauer, Christoph; Kinzler, Kenneth W.; Vogelstein, Bert; Papadopoulos, Nickolas.

In: Science, Vol. 325, No. 5947, 2009, p. 1555-1559.

Research output: Contribution to journalArticle

Yun, J, Rago, C, Cheong, I, Pagliarini, R, Angenendt, P, Rajagopalan, H, Schmidt, K, Willson, JKV, Markowitz, S, Zhou, S, Diaz, LA, Velculescu, VE, Lengauer, C, Kinzler, KW, Vogelstein, B & Papadopoulos, N 2009, 'Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells', Science, vol. 325, no. 5947, pp. 1555-1559. https://doi.org/10.1126/science.1174229
Yun J, Rago C, Cheong I, Pagliarini R, Angenendt P, Rajagopalan H et al. Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells. Science. 2009;325(5947):1555-1559. https://doi.org/10.1126/science.1174229
Yun, Jihye ; Rago, Carlo ; Cheong, Ian ; Pagliarini, Ray ; Angenendt, Philipp ; Rajagopalan, Harith ; Schmidt, Kerstin ; Willson, James K V ; Markowitz, Sandy ; Zhou, Shibin ; Diaz, Luis A. ; Velculescu, Victor E. ; Lengauer, Christoph ; Kinzler, Kenneth W. ; Vogelstein, Bert ; Papadopoulos, Nickolas. / Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells. In: Science. 2009 ; Vol. 325, No. 5947. pp. 1555-1559.
@article{4fc2382c4f5845ca96a2ef742b0cb0e2,
title = "Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells",
abstract = "Tumor progression is driven by genetic mutations, but little is known about the environmental conditions that select for these mutations. Studying the transcriptomes of paired colorectal cancer cell lines that differed only in the mutational status of their KRAS or BRAF genes, we found that GLUT1, encoding glucose transporter-1, was one of three genes consistently up-regulated in cells with KRAS or BRAF mutations. The mutant cells exhibited enhanced glucose uptake and glycolysis and survived in low-glucose conditions, phenotypes that all required GLUT1 expression. In contrast, when cells with wild-type KRAS alleles were subjected to a low-glucose environment, very few cells survived. Most surviving cells expressed high levels of GLUT1, and 4{\%} of these survivors had acquired KRAS mutations not present in their parents. The glycolysis inhibitor 3-bromopyruvate preferentially suppressed the growth of cells with KRAS or BRAF mutations. Together, these data suggest that glucose deprivation can drive the acquisition of KRAS pathway mutations in human tumors.",
author = "Jihye Yun and Carlo Rago and Ian Cheong and Ray Pagliarini and Philipp Angenendt and Harith Rajagopalan and Kerstin Schmidt and Willson, {James K V} and Sandy Markowitz and Shibin Zhou and Diaz, {Luis A.} and Velculescu, {Victor E.} and Christoph Lengauer and Kinzler, {Kenneth W.} and Bert Vogelstein and Nickolas Papadopoulos",
year = "2009",
doi = "10.1126/science.1174229",
language = "English (US)",
volume = "325",
pages = "1555--1559",
journal = "Science",
issn = "0036-8075",
publisher = "American Association for the Advancement of Science",
number = "5947",

}

TY - JOUR

T1 - Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells

AU - Yun, Jihye

AU - Rago, Carlo

AU - Cheong, Ian

AU - Pagliarini, Ray

AU - Angenendt, Philipp

AU - Rajagopalan, Harith

AU - Schmidt, Kerstin

AU - Willson, James K V

AU - Markowitz, Sandy

AU - Zhou, Shibin

AU - Diaz, Luis A.

AU - Velculescu, Victor E.

AU - Lengauer, Christoph

AU - Kinzler, Kenneth W.

AU - Vogelstein, Bert

AU - Papadopoulos, Nickolas

PY - 2009

Y1 - 2009

N2 - Tumor progression is driven by genetic mutations, but little is known about the environmental conditions that select for these mutations. Studying the transcriptomes of paired colorectal cancer cell lines that differed only in the mutational status of their KRAS or BRAF genes, we found that GLUT1, encoding glucose transporter-1, was one of three genes consistently up-regulated in cells with KRAS or BRAF mutations. The mutant cells exhibited enhanced glucose uptake and glycolysis and survived in low-glucose conditions, phenotypes that all required GLUT1 expression. In contrast, when cells with wild-type KRAS alleles were subjected to a low-glucose environment, very few cells survived. Most surviving cells expressed high levels of GLUT1, and 4% of these survivors had acquired KRAS mutations not present in their parents. The glycolysis inhibitor 3-bromopyruvate preferentially suppressed the growth of cells with KRAS or BRAF mutations. Together, these data suggest that glucose deprivation can drive the acquisition of KRAS pathway mutations in human tumors.

AB - Tumor progression is driven by genetic mutations, but little is known about the environmental conditions that select for these mutations. Studying the transcriptomes of paired colorectal cancer cell lines that differed only in the mutational status of their KRAS or BRAF genes, we found that GLUT1, encoding glucose transporter-1, was one of three genes consistently up-regulated in cells with KRAS or BRAF mutations. The mutant cells exhibited enhanced glucose uptake and glycolysis and survived in low-glucose conditions, phenotypes that all required GLUT1 expression. In contrast, when cells with wild-type KRAS alleles were subjected to a low-glucose environment, very few cells survived. Most surviving cells expressed high levels of GLUT1, and 4% of these survivors had acquired KRAS mutations not present in their parents. The glycolysis inhibitor 3-bromopyruvate preferentially suppressed the growth of cells with KRAS or BRAF mutations. Together, these data suggest that glucose deprivation can drive the acquisition of KRAS pathway mutations in human tumors.

UR - http://www.scopus.com/inward/record.url?scp=70349331678&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349331678&partnerID=8YFLogxK

U2 - 10.1126/science.1174229

DO - 10.1126/science.1174229

M3 - Article

VL - 325

SP - 1555

EP - 1559

JO - Science

JF - Science

SN - 0036-8075

IS - 5947

ER -